Spyre Therapeutics target price raised to $141 from $123
SYRE•Deutsche Bank raised its target price for Spyre Therapeutics to $141 from $123.
Related News
AMETEK: Truist Securities raises target price to $329 from $316
AME•
Keurig Dr Pepper slides on $2 billion equity raise for debt reduction
KDP•
DoorDash: Rosenblatt Securities cuts target price to $210 from $225
DASH•
Tvardi Therapeutics Q3 net loss widens slightly less than expected
TVRD•
Cerrado Gold acquires Manantial Espejo mine from Pan American Silver
PAAS•